Subjects

On this page readers can obtain a listing of documents under the subject headings. Click on the name of a subject heading to display the sub-headings, or to return to the main subjects. Click on the icon of a sub-heading to obtain the concerned documents. Publications are available in HTML, PDF , DOC or XLS format. Click on the corresponding icon to open the publication. The PDF icon located on the cover page of a publication represents that the publication is available only in PDF format. If the PDF icon is located near the title of the publication it means the document is available in both HTML and PDF formats.
Expand the sub-collections menu.
153 documents on 1 page
 
 
 
 
Open this document and view its content

Access to Antiretroviral Drugs in Low- and Middle-income Countries: Technical Report, July 2014

Year:

2014;

Pages:

44;


Regions:

 
Open this document and view its content

Better Life Through Medicine—let’s Leave No One Behind. (Essential Medicines for Universal Health Coverage - Comment. The Lancet Commission on Essential Medicines Policies)

Year:

2016;

Pages:

2;

Regions:

 
Open this document and view its content

China Policies to Promote Local Production of Pharmaceutical Products and Protect Public Health

Year:

2017;

Pages:

60;


Related documents:

Countries:

 
Open this document and view its content

Data Exclusivity Exceptions and Compulsory Licensing to Promote Generic Medicines in the European Union: A Proposal for Greater Coherence in European Pharmaceutical Legislation

Year:

2017;

Pages:

9;

Related documents:

 
Open this document and view its content

Developing Socially Responsible Intellectual Property Licensing Policies: Non-exclusive Licensing Initiatives in the Pharmaceutical Sector. (Research Handbook on Intellectual Property Licensing, Chapter 10)

Year:

2013;

Pages:

32;

Related documents:

Regions:

 
Open this document and view its content

Ensuring that Essential Medicines are also Affordable Medicines: Challenges and Options. Discussion Paper UNITAID

Year:

2016;

Pages:

52;


Related documents:

Regions:

 
Open this document and view its content

Essential Medicines for Universal Health Coverage. (Essential Medicines for Universal Health Coverage - Comment. The Lancet Commission on Essential Medicines Policies)

Year:

2016;

Pages:

2;

Regions:

 
Open this document and view its content

Essential Medicines for Universal Health Coverage. (The Lancet Commission on Essential Medicines Policies)

Year:

2016;

Pages:

74;


Regions:

 
Open this document and view its content

Flexibilities provided by the Agreement on Trade-Related Aspects of Intellectual Property Rights. (Bull World Health Organ 2018;96:148)

Year:

2018;

Pages:

2;


Related documents:

Regions:

 
Open this document and view its content

Global Access to Hepatitis Drugs and Diagnostics Consultation with Pharmaceutical and Diagnostics Companies. 16 June 2014, Geneva, Switzerland

Year:

2014;

Pages:

24;


Related documents:

Regions:

 
Open this document and view its content

The Global Intellectual Property Ecosystem for Insulin and Its Public Health Implications: An Observational Study

Year:

2016;

Pages:

9;

Related documents:

Regions:

 
Open this document and view its content

Global Report on Access to Hepatitis C Treatment. Focus on Overcoming Barriers. October 2016

Year:

2016;

Pages:

68;


Related documents:

Regions:

 
Open this document and view its content

How Patent Law Reform Can Improve Affordability and Accessibility of Medicines in South Africa: Four Medicine Case Studies

Year:

2019;

Pages:

5;

Related documents:

Regions:

Countries:

 
Open this document and view its content

Improved Effectiveness of Generic Medicine Markets in Hungary. Analysis and Recommendations

Year:

2015;

Pages:

98;


Related documents:

Countries:

 
Open this document and view its content

Indian policies to promote local production of pharmaceutical products and protect public health

Year:

2017;

Pages:

60;


Related documents:

Countries:

 
Open this document and view its content

Informal Consultation on Access to Hepatitis Medicines in Upper-Middle-and High Income Countries. 21–22 August 2017, Manila, Philippines

Year:

2017;

Pages:

23;


Related documents:

Regions:

 
Open this document and view its content

Insulin Patent Profile. April 2016

Year:

2016;

Pages:

64;


Related documents:

Regions:

 
Open this document and view its content

The International Debate on Generic Medicines of Biological Origin (The South Centre - Research Papers 82, November 2017)

Year:

2017;

Pages:

40;

Publishers:


Related documents:

Regions:

 
Open this document and view its content

Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?

Year:

2016;

Pages:

13;

Regions:

 
Open this document and view its content

Medicine Procurement and the Use of Flexibilities in the Agreement on Trade-related Aspects of Intellectual Property Rights, 2001–2016. (Bull World Health Organ 2018;96:185–193)

Year:

2018;

Pages:

9;


Related documents:

Regions:

 
Open this document and view its content

Patent Pooling to Increase Access to Essential Medicines (Bull World Health Organ 2019; 97:575–577)

Year:

2019;

Pages:

3;


Regions:

 
Open this document and view its content

Patent Situation of Key Products for Treatment of Hepatitis C – Daclatasvir. Working Paper, Update and Revised Version June 2016

Year:

2016;

Pages:

26;


Related documents:

Regions:

 
Open this document and view its content

Patent Situation of Key Products for Treatment of Hepatitis C – Ledipasvir. Working Paper, Updated and Revised Version June 2016

Year:

2016;

Pages:

24;


Related documents:

Regions:

 
Open this document and view its content

Patent Situation of Key Products for Treatment of Hepatitis C – Paritaprevir/Ombitasvir/Dasabuvir. Working Paper, Revised Version June 2016

Year:

2016;

Pages:

39;


Related documents:

Regions:

 
Open this document and view its content

Patent Situation of Key Products for Treatment of Hepatitis C – Simeprevir. Working Paper, Updated and Revised Version June 2016

Year:

2016;

Pages:

29;


Related documents:

Regions:

 
Open this document and view its content

Patent Situation of Key Products for Treatment of Hepatitis C – Sofosbuvir. Working Paper, Updated and Revised Version June 2016

Year:

2016;

Pages:

37;


Related documents:

Regions:

 
Open this document and view its content

Private Patents and Public Health. Changing Intellectual Property Rules for Access to Medicines

Year:

2016;

Pages:

194;


Related documents:

Regions:

 
Open this document and view its content

Progress report on access to hepatitis C treatment. Focus on overcoming barriers in low- and middle-income countries. March 2018

Year:

2018;

Pages:

68;


Related documents:

Regions:

 
Open this document and view its content

Report of the United Nations Secretary-General’s High-Level Panel on Access to Medicines. Promoting innovation and access to health technologies. September 2016

Year:

2016;

Pages:

70;


Regions:

 
Open this document and view its content

The Role of Intellectual Property in Local Production in Developing Countries. Opportunities and Challenges

Year:

2016;

Pages:

56;


Related documents:

Regions:

 
Open this document and view its content

Scaling up for Universal Health Coverage. (Essential Medicines for Universal Health Coverage - Comment. The Lancet Commission on Essential Medicines Policies)

Year:

2016;

Pages:

3;

Regions:

 
Open this document and view its content

Sri Lanka's national assessment on innovation and intellectual property for access to medical products (WHO South-East Asia Journal of Public Health | September 2016)

Year:

2016;

Pages:

4;


Related documents:

Countries:

 
Open this document and view its content

Technology and Market Landscape for Hepatitis C Medicines. August 2017

Year:

2017;

Pages:

140;


Related documents:

Regions:

 
Open this document and view its content

Towards Open Science: Promoting Innovation in Pharmaceutical Research and Development and Access to Affordable Medications both in Canada and Abroad. Report of the Standing Committee on Health, November 2018, 42nd Parliament, 1st Session. House of Commons, Canada

Year:

2018;

Pages:

38;


Related documents:

Countries:

 
Open this document and view its content

Towards Realizing Access to Essential Medicines for All : A Vision for 2035. The Lancet Youth Commission on Essential Medicines Policies (YCEMP) - Report

Year:

2016;

Pages:

73;


Regions:

 
Open this document and view its content

Trade-Related Aspects of Intellectual Property Rights (TRIPS) and Access to Medicines. Focusing the Analysis in the Americas. Report of the Working Group, Managua, Nicaragua, 14-16 April 2004

Year:

2004;

Pages:

15;


Related documents:

 
Open this document and view its content

Using Competition Law to Promote Access to Health Technologies. A Guidebook for Low-and-middle Income Countries

Year:

2014;

Pages:

170;


Regions:

 
Open this document and view its content

Youth Demand Action on the Shared Global Challenge Of Access to Medicines. (Essential Medicines for Universal Health Coverage - Comment. The Lancet Commission on Essential Medicines Policies)

Year:

2016;

Pages:

2;


Regions:

 
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019